Frequently Asked Questions

Reto is an AI-powered technology ecosystem that combines continuing medical education, simulated clinical practice, and advanced data analytics. Unlike static medical directories or traditional exam-preparation tools that function as a "temporary toll booth," Reto supports healthcare professionals throughout their entire professional lifecycle—from graduation through mandatory recertification processes every five years. Today, we have a critical mass of more than 66,000 physicians, reaching approximately 25% of the general medicine market in Mexico and up to 85% of residents in key specialties.

Reto operates through a scalable two-sided model that maximizes the Lifetime Value (LTV) of our community. For healthcare professionals, access to daily clinical update pathways is free or sponsored through institutional scholarships. For the business sector—including multinational pharmaceutical companies, medical device (MedTech) companies, hospitals, and universities—Reto operates as a data intelligence SaaS platform through solutions such as campaigns, educational sponsorships, market research, and personalized medical education. We replace the inefficiency of traditional medical marketing with highly traceable, analytics-driven strategies, enabling the industry to understand real clinical knowledge gaps in specific therapeutic areas.

Trust and regulatory compliance are core assets of our organization. Reto operates under strict data governance that fully complies with Mexico’s Federal Law on the Protection of Personal Data Held by Private Parties (LFPDPPP) and COFEPRIS guidelines for the ethical communication and promotion of health-related products. All commercial intelligence, market research, and educational reports distributed to institutional clients are processed in a strictly aggregated and anonymized manner; under no circumstances is identifiable user information commercialized without explicit consent. Additionally, our cloud infrastructure uses private channels and automatic encryption of data in transit and at rest, and is prepared to meet global regulations such as HIPAA and GDPR.

With projected sales growth of more than 300% by year-end and a clear goal of reaching operational break-even in the fourth quarter, Reto is executing its Seed Round during the third quarter of 2026 to accelerate its institutional expansion plan. The strategic pipeline includes the launch of the Reto Nursing vertical and the deployment of our multilingual platform in high-value markets across the region, including Latin America and the Spanish-speaking market in the United States, leveraging partnerships with leading medical societies and hospital networks.